Advisory Board and Editors Biophysics

Author Instructions Factsheet
Journal Factsheet
A one-page PDF to help when considering journal options with co-authors
Download Factsheet
I told my colleagues that PeerJ is a journal where they need to publish if they want their paper to be published quickly and with the strict peer review expected from a good journal.
Sohath Vanegas,
PeerJ Author
Quotation Mark
View author feedback
picture of Rudi H. Ettrich

Rudi H. Ettrich

Rudi received his prediploma in chemistry (Vordiplom) from Eberhard-Karls-University, Tuebingen, Germany, in 1993, his Master of sciences (Mgr.) in physical and macromolecular chemistry from Charles University, Prague, in 1998 and his PhD. in physical chemistry from Charles University, Prague, in 2002.
Since 2013 he is a full Professor (Prof.) in biophysics and currently acts as the President/CEO of Larkin University, Miami, FL and holds a faculty appointment at the College of Biomedical Sciences. He also holds community-based adjunct faculty positions at the Wertheim College of Medicine, Florida International University, Miami, FL, and the Department of Mathematics and Physics, Charles University, Czechia.

Prior to joining Larkin University Rudi was affiliated with the Czech Academy of Sciences, where he acted as director, group leader and senior researcher at the Center for Nanobiology and Structural Biology of the Institute of Microbiology in Nové Hrady, Academy of Sciences of the Czech Republic

Rudi's research is focused on the relationship between structure and function of proteins, dynamic changes related to functional processes on the level of proteins and the mutual interaction of cofactors and subunits in protein complexes. The research approach is very complex using various methods of protein research with a synthesis of theoretical and experimental methods.

picture of Takashi Funatsu

Takashi Funatsu

Takashi Funatsu received his BS, MS and PhD degrees from Waseda University in 1982, 1984 and 1988, respectively. He was an associate professor at Waseda University in 1997. Since 2004, he has been a professor of Graduate School of Pharmaceutical Sciences, The University of Tokyo. His research interests are (1) Elucidating the molecular mechanism of bio-molecular machine, such as a molecular chaperonin, (2) Single molecule imaging of processing and transport of mRNA in a living cell, and (3) Development of micro/nano devices to analyze bio-molecular interactions.

picture of Rita Grandori

Rita Grandori

Professor of Biochemistry at the Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy. Adjunct Professor of Protein Science at the Institute of Organic Chemistry, Johannes Kepler University, Linz, Austria.

picture of Hidekazu Hiroaki

Hidekazu Hiroaki

Dr. Hidekazu Hiroaki is Professor within the Graduate School of Pharmaceutical Sciences, Nagoya University, Japan. He received his PhD in Pharmaceutical Sciences (PhD thesis "Spectroscopic study for interaction between DNA oligonucleotide and bleomycin”) from the Graduate School of Osaka University, Japan in 1992.

Dr Hiroaki's research focuses on the structural biology of proteins by using solution NMR techniques, including protein-protein and protein-drug interaction. He is also focusing on NMR-assisted in silico drug discovery as well as protein structure determination. He is also an expert of intrinsically disordered proteins and some disease related amyloid genic proteins.

Professional experience:
2012-present: Professor, Graduate School of Pharmaceutical Sciences, Nagoya University (Nagoya, Aichi, Japan)
2011-2012: Professor, Research Center for Structural Biology, Department of Science, Nagoya University (Nagoya, Aichi, Japan)
2007-2011: Professor, Division of Structural Biology, Graduate School of Medicine, Kobe University, (Kobe, Hyogo, Japan)
2001-2007: Associate Professor, International Graduate School of Art and Science, Yokohama City University, (Kanagawa, Japan)
1995-2001: Research Scientist, Division of Structural Biology, Biomolecular Engineering Research Institute (BERI) (Suita, Osaka, Japan)
1994-1995: Visiting Scientist, Research Centre, F Hoffman La Roche (Basel, Switzerland)
1992-1994: Research Scientist, Department of Molecular Genetics, Nippon Roche Research Center (Kanagawa, Japan)

picture of John R Hutchinson

John R Hutchinson

Professor of Evolutionary Biomechanics at The Royal Veterinary College, University of London. Assoc Editor of Proc Roy Soc B, J Theor Biol. Royal Society Leverhulme Trust Senior Fellow 2012-2013. Fellow of the Linnean Society of London, Anatomical Society, Zoological Society of London and Royal Society of Biology. RCVS Share Jones Lecture in Anatomy (2011) and British Science Festival, Charles Darwin Award Lecture (2012). Honorary Research Associate, University College London. Fellow of the Year, Anatomical Society (2015).

picture of Łukasz Jaremko

Łukasz Jaremko

Dr. Łukasz Jaremko is Associate Professor at King Abdullah University of Science and Technology.

Research in Dr. Jaremko's Molecular Diagnostics and Drug Discovery (MD3) group focuses on atomic-level insight into essential and topical questions from biochemistry and medicine.

picture of Mikko Karttunen

Mikko Karttunen

Canada Research Chair (Tier 1) in Computational Materials and Biomaterials Research and Professor of Chemistry & Applied Mathematics at the University of Western Ontario. Leader of the Computational and Theoretical Biological Physics & Chemistry Group. Affiliate of the Perimeter Institute for Theoretical Physics at Waterloo.

Selected Awards: Ontario Early Reseachers Award, NSERC Discovery Accelerator, EU DEISA Extreme Computing, Distinguished Research Professor, Academy of Finland Fellowship

picture of Alex Kentsis

Alex Kentsis

Assistant Professor of Pediatrics at the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College of Cornell University.

He leads research in the functional proteomics and genomic plasticity of refractory childhood cancers.

picture of Alla S Kostyukova

Alla S Kostyukova

Associate Professor at Voiland School of Chemical Engineering & Bioengineering. Former director of the Circular Dichroism facility at Robert Wood Johnson Medical School, Piscataway, NJ.

picture of Carmelo La Rosa

Carmelo La Rosa

Carmelo La Rosa is a Professor of Physical-Chemistry at the University of Catania, Italy. He received a master’s degree in Chemistry and Ph.D. in Physical-Chemistry from the University of Catania (Italy), working on lyotropic liquid crystals. After completing postdoctoral training on thermodynamics and kinetics of protein folding-unfolding at the University of Catania and Leiden University (The Netherland), he joined the department of Chemical Sciences, University of Catania. His current research focuses on the biophysics of amyloidogenic proteins and their interaction with model membranes.

picture of Raphaël Lévy

Raphaël Lévy

PhD, physics, Strasbourg, France, 2002, polymer adsorption with the Atomic Force Microscope

Post-doctoral fellowship, Liverpool, UK, Design of peptides as capping agents for gold nanoparticles

BBSRC David Phillips Fellow, Liverpool, 2006-11, Nanoparticle-based imaging in living cells; biomimetic nanoparticles
2011- Lecturer, then Senior Lecturer, University of Liverpool

Our research focuses on nanoparticles, their structure, and applications, in particular for biological imaging both at the single molecule level and for cell tracking in animal models.

picture of Ning Li

Ning Li

Prof. Li received his Medical Doctorate in 2005 as an outstanding graduate of the Chinese Union Medical University (CUMU). In the same year, he worked in the Department of Thoracic Surgery at the Cancer Hospital of the Chinese Academy of Medical Sciences, where he served as an attending physician, deputy chief physician, and was appointed Chief Physician in 2019. He has a solid theoretical foundation and excellent research ability, and has accumulated rich clinical experience during my work. In 2017, he took over as the Director of the Office of Drug Clinical Trial Research Center, and his outstanding achievements in the management of clinical trial institutions and clinical and translational research, and is currently served as the chief expert of China GCP platform and Leading PI of international multicenter clinical trials of anti-cancer drug discovery. He is committed to new anti-tumor drug research, real-world research, full chain translation research of clinical trials, precision treatment of rare tumors and tumor big data research. His H-Index is 44 based on Web of Science. As a sub-project leader of the National 973 Major Project, the National Key R&D Program for Precision Medicine, the National Natural Science Foundation of China, the GCP platform leader, and the leader of the 13th and 14th Five-Year Innovation Project, he has undertaken many research projects.